S100A8 and familial pancreatic carcinoma: Among the six studies examining the infection rate of Cag+ H. pylori (including one study detecting CagA and VacA), the prevalence of CagA+ H. pylori ranged from 14.7% to 60.3% in pancreatic cancer patients, and from 7% to 84.7% in the controls.